Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
Mirum Pharmaceuticals, Inc. (MIRM) had Gross Margin of 81.06% for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$185.72M |
|
$-40.77M |
|
$35.17M |
|
$150.55M |
|
$245.47M |
|
$-59.75M |
|
$19.52M |
|
$-40.23M |
|
$-40.23M |
|
$-40.77M |
|
$-40.77M |
|
$-40.77M |
|
$-40.77M |
|
$-59.75M |
|
$-52.01M |
|
65.53M |
|
66.05M |
|
$-0.62 |
|
$-0.87 |
|
| Balance Sheet Financials | |
$586.63M |
|
$3.25M |
|
$439.98M |
|
$1.03B |
|
$283.08M |
|
$731.25M |
|
$797.72M |
|
$1.08B |
|
$-54.19M |
|
$-329.83M |
|
$-54.19M |
|
65.21M |
|
| Cash Flow Statement Financials | |
$-277.33M |
|
$-200.43M |
|
$427.17M |
|
$298.17M |
|
$244.92M |
|
$-53.24M |
|
$100.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.07 |
|
-- |
|
-- |
|
1.08 |
|
-13.50 |
|
|
Gross Margin |
81.06% |
-32.17% |
|
-32.17% |
|
-- |
|
-21.66% |
|
-21.95% |
|
$-279.32M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
1.38 |
|
1.19 |
|
75.77 |
|
75.23% |
|
12.36% |
|
-3.97% |
|
-6.02% |
|
$-0.83 |
|
$-4.23 |
|
$-4.20 |
|